BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26774561)

  • 1. Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.
    Yoshizumi T; Zhu Y; Jiang H; D'Amore A; Sakaguchi H; Tchao J; Tobita K; Wagner WR
    Biomaterials; 2016 Mar; 83():182-93. PubMed ID: 26774561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.
    Dorsey SM; McGarvey JR; Wang H; Nikou A; Arama L; Koomalsingh KJ; Kondo N; Gorman JH; Pilla JJ; Gorman RC; Wenk JF; Burdick JA
    Biomaterials; 2015 Nov; 69():65-75. PubMed ID: 26280951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction.
    Matsumura Y; Zhu Y; Jiang H; D'Amore A; Luketich SK; Charwat V; Yoshizumi T; Sato H; Yang B; Uchibori T; Healy KE; Wagner WR
    Biomaterials; 2019 Oct; 217():119289. PubMed ID: 31254935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: a translational approach: Vu and Pal "Myocardial Repair: PRP, Hydrogel and Supplements".
    Vu TD; Pal SN; Ti LK; Martinez EC; Rufaihah AJ; Ling LH; Lee CN; Richards AM; Kofidis T
    Biomaterials; 2015 Mar; 45():27-35. PubMed ID: 25662492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction.
    Rane AA; Chuang JS; Shah A; Hu DP; Dalton ND; Gu Y; Peterson KL; Omens JH; Christman KL
    PLoS One; 2011; 6(6):e21571. PubMed ID: 21731777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hydrogel injection on cardiac function and myocardial mechanics in a computational post-infarction model.
    Kortsmit J; Davies NH; Miller R; Macadangdang JR; Zilla P; Franz T
    Comput Methods Biomech Biomed Engin; 2013; 16(11):1185-95. PubMed ID: 22439799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widely distributable and retainable in-situ gelling material for treating myocardial infarction.
    Le HT; Mahara A; Fukazawa K; Nagasaki T; Yamaoka T
    Acta Biomater; 2024 Mar; 176():221-233. PubMed ID: 38242190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction.
    Mathieu E; Lamirault G; Toquet C; Lhommet P; Rederstorff E; Sourice S; Biteau K; Hulin P; Forest V; Weiss P; Guicheux J; Lemarchand P
    PLoS One; 2012; 7(12):e51991. PubMed ID: 23284842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
    Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
    J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
    Wassenaar JW; Gaetani R; Garcia JJ; Braden RL; Luo CG; Huang D; DeMaria AN; Omens JH; Christman KL
    J Am Coll Cardiol; 2016 Mar; 67(9):1074-1086. PubMed ID: 26940929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
    Leor J; Tuvia S; Guetta V; Manczur F; Castel D; Willenz U; Petneházy O; Landa N; Feinberg MS; Konen E; Goitein O; Tsur-Gang O; Shaul M; Klapper L; Cohen S
    J Am Coll Cardiol; 2009 Sep; 54(11):1014-23. PubMed ID: 19729119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable OPF/graphene oxide hydrogels provide mechanical support and enhance cell electrical signaling after implantation into myocardial infarct.
    Zhou J; Yang X; Liu W; Wang C; Shen Y; Zhang F; Zhu H; Sun H; Chen J; Lam J; Mikos AG; Wang C
    Theranostics; 2018; 8(12):3317-3330. PubMed ID: 29930732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan hydrogels significantly limit left ventricular infarction and remodeling and preserve myocardial contractility.
    Henning RJ; Khan A; Jimenez E
    J Surg Res; 2016 Apr; 201(2):490-7. PubMed ID: 27020836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.
    Singelyn JM; Sundaramurthy P; Johnson TD; Schup-Magoffin PJ; Hu DP; Faulk DM; Wang J; Mayle KM; Bartels K; Salvatore M; Kinsey AM; Demaria AN; Dib N; Christman KL
    J Am Coll Cardiol; 2012 Feb; 59(8):751-63. PubMed ID: 22340268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
    Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
    Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the HeartLander crawling robot for injection of a thermally sensitive anti-remodeling agent for myocardial infarction therapy.
    Chapman MP; Lopez Gonzalez JL; Goyette BE; Fujimoto KL; Ma Z; Wagner WR; Zenati MA; Riviere CN
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():5428-31. PubMed ID: 21096276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.
    Ghali R; Habeichi NJ; Kaplan A; Tannous C; Abidi E; Bekdash A; Farhat R; Itani H; Jurjus A; Booz GW; Mallat Z; Zouein FA
    Clin Sci (Lond); 2020 Jun; 134(11):1191-1218. PubMed ID: 32432676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable Shear-Thinning Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left Ventricular Remodeling.
    Rodell CB; Lee ME; Wang H; Takebayashi S; Takayama T; Kawamura T; Arkles JS; Dusaj NN; Dorsey SM; Witschey WR; Pilla JJ; Gorman JH; Wenk JF; Burdick JA; Gorman RC
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27729419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and temporal changes in left ventricular strain and stiffness in a porcine model of myocardial infarction.
    Torres WM; Jacobs J; Doviak H; Barlow SC; Zile MR; Shazly T; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H958-H967. PubMed ID: 30004234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.